Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Current Assets (2023 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Current Assets for 3 consecutive years, with $221.6 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 45.83% to $221.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $221.6 million through Dec 2025, up 45.83% year-over-year, with the annual reading at $221.6 million for FY2025, 45.83% up from the prior year.
  • Current Assets hit $221.6 million in Q4 2025 for Guardian Pharmacy Services, up from $198.3 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $221.6 million in Q4 2025 to a low of $129.6 million in Q4 2023.
  • Historically, Current Assets has averaged $174.0 million across 3 years, with a median of $170.5 million in 2025.
  • Biggest YoY gain for Current Assets was 45.83% in 2025; the steepest drop was 9.99% in 2025.
  • Year by year, Current Assets stood at $129.6 million in 2023, then increased by 17.27% to $152.0 million in 2024, then surged by 45.83% to $221.6 million in 2025.
  • Business Quant data shows Current Assets for GRDN at $221.6 million in Q4 2025, $198.3 million in Q3 2025, and $170.5 million in Q2 2025.